.png)
.png)
WuXi TIDES Forum and Reception Dinner
In recent years, we have seen a huge surge of interest in oligonucleotide and peptide therapeutics, with many new drug approvals and a strong pipeline of discovery and development-stage molecules. The industry has made significant progress in understanding how to make such molecules stable, selective, and efficient. However, we are still faced with various challenges in converting the breadth of potential applications into patient-ready treatments.
WuXi TIDES Forum: Accelerating Oligonucleotide Therapeutics from Concept to Patients
In this forum, industry thought leaders will discuss some of the challenges that delay development at different stages and the solutions to accelerate oligo therapeutics from concept to patients. Their insights will cover a wide range of topics in the discovery and development of this new modality area through a series of presentations and a panel discussion.
Speakers:
WuXi TIDES Forum: Accelerating Oligonucleotide Therapeutics from Concept to Patients
In this forum, industry thought leaders will discuss some of the challenges that delay development at different stages and the solutions to accelerate oligo therapeutics from concept to patients. Their insights will cover a wide range of topics in the discovery and development of this new modality area through a series of presentations and a panel discussion.
Speakers:
- Dr. Ekkehard Leberer, Senior Life Sciences Consultant at Elbiocon
- Timothy Weeden, Vice President, Head of Platform Development at Dyne Therapeutics
- Dr. Dave Madge, Vice President, Discovery Services at WuXi AppTec.
- Dr. Pete Nguyen, Senior Director of Oligo and Peptide Business at WuXi STA.
Free